T2 Biosystems, Inc. (NASDAQ:TTOO) shareholders will have a reason to smile today, with the analysts making substantial...: T2 Biosystems, Inc. (NASDAQ:TTOO) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's forecasts. Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with the analysts modelling a real improvement in business performance. Following the upgrade, the latest consensus from T2 Biosystems' four analysts is for revenues of US$42m in 2021, which would reflect a substantial 211% improvement in sales compared to the last 12 months.